Abbott: Abbott launches intravascular lithotripsy trial aimed at clearing coronary arteries
Abbott's investigational Coronary Intravascular Lithotripsy (IVL) System offers a new potential treatment by using sound pressure waves to treat arterial calcium blockages
Read full article »
Chairman & CEO
Robert B. Ford
Abbott is an Illinois-based healthcare company that develops and markets medical devices in fields such as neuroscience and diabetes.
Read more